Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sahil Khanna

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Expert Opinion on Pharmacotherapy|February 18, 2026
What potential do DNA polymerase IIIC (PolC) inhibitors hold for the treatment of <i>clostridioides difficile</i> infection?Sahil Khanna
Panminerva Medica|October 9, 2024
Microbiota restoration for recurrent Clostridioides difficile infectionSahil Khanna
Intestinal Research|August 19, 2020
Management of Clostridioides difficile infection in patients with inflammatory bowel diseaseSahil Khanna
Mayo Clinic Proceedings|November 6, 2020
Gut Involvement by COVID-19Sahil Khanna
Expert Review of Anti-Infective Therapy|January 11, 2021
Advances in <i>Clostridioides difficile</i> therapeuticsSahil Khanna
Mayo Clinic Proceedings|June 27, 2021
My Treatment Approach to Clostridioides difficile InfectionSahil Khanna
The Lancet. Infectious Diseases|September 18, 2020
Defending against a difficult clostridioides with a vaccineSahil Khanna
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 18, 2026
Specialty grand challenge in gastrointestinal infectionsSahil Khanna
Therapeutic Advances in Gastroenterology|May 4, 2026
Responsible use of large language models in gastroenterology and hepatologySahil Khanna
The Lancet. Gastroenterology & Hepatology|February 25, 2021
A defined microbiome therapeutic prevents recurrent Clostridioides difficileSahil Khanna
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Expert Opinion on Pharmacotherapy|February 18, 2026
What potential do DNA polymerase IIIC (PolC) inhibitors hold for the treatment of <i>clostridioides difficile</i> infection?Sahil Khanna
Panminerva Medica|October 9, 2024
Microbiota restoration for recurrent Clostridioides difficile infectionSahil Khanna
Intestinal Research|August 19, 2020
Management of Clostridioides difficile infection in patients with inflammatory bowel diseaseSahil Khanna
Mayo Clinic Proceedings|November 6, 2020
Gut Involvement by COVID-19Sahil Khanna
Expert Review of Anti-Infective Therapy|January 11, 2021
Advances in <i>Clostridioides difficile</i> therapeuticsSahil Khanna
Mayo Clinic Proceedings|June 27, 2021
My Treatment Approach to Clostridioides difficile InfectionSahil Khanna
The Lancet. Infectious Diseases|September 18, 2020
Defending against a difficult clostridioides with a vaccineSahil Khanna
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 18, 2026
Specialty grand challenge in gastrointestinal infectionsSahil Khanna
Therapeutic Advances in Gastroenterology|May 4, 2026
Responsible use of large language models in gastroenterology and hepatologySahil Khanna
The Lancet. Gastroenterology & Hepatology|February 25, 2021
A defined microbiome therapeutic prevents recurrent Clostridioides difficileSahil Khanna
Pageof 26